ALNY · Alnylam Pharmaceuticals, Inc.
$228.65
+1.53 (+0.67%)
At close · Aug 14
Market Cap
$30.60B
Shares
133.81M
Fails to deliver — shares from a trade that were not delivered to the buyer by the settlement date — published by the SEC twice a month. Persistent fails can reflect settlement problems or naked short selling.
Fails to Deliver History
| Settlement Date | Quantity | Price | Value |
|---|---|---|---|
| 2026-07-13 | 4 | $298.76 | $1,195 |
| 2026-07-09 | 3,683 | $323.50 | $1,191,451 |
| 2026-07-08 | 3,745 | $321.59 | $1,204,355 |
| 2026-07-01 | 3,004 | $301.03 | $904,294 |
| 2026-06-22 | 6 | $278.09 | $1,669 |
| 2026-06-18 | 4 | $282.72 | $1,131 |
| 2026-06-12 | 22,234 | $289.39 | $6,434,297 |
| 2026-06-09 | 75 | $292.16 | $21,912 |
| 2026-06-08 | 6,664 | $303.05 | $2,019,525 |
| 2026-06-05 | 6,912 | $303.64 | $2,098,760 |
Showing 1–10 of 10 settlements
Key facts
CIK
1178670
CUSIP
02043Q107
13F (30d)
739 filings
705 filers
Visit website
Investor relations